Teladoc Health, Inc. · NYSE:TDOC
Teladoc Health — Investor Presentation (January 2019)
16 slides from Teladoc Health's investor presentation, Jan 7, 2019
Slide 1: Safe harbor
Safe harbor This presentation contains, and our officers may make, “forward-looking” statements that are based on our management’s beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitation, information concerning possib
Slide 2: Teladoc Health investment highlights
Teladoc Health investment highlights Global footprint with significant growth opportunities Industry leader with strong competitive positioning Accelerating utilization rates across populations Compelling financial model The only comprehensive virtual care delivery solution
Slide 3: Teladoc at a Glance
Revenue & Profitability ($ in millions) (1) Total Consolidated Visits (thousands) (1) Highlights(1) Teladoc at a Glance (1) Full-year and quarter management guidance; midpoint of range, unless otherwise noted. 84% Revenue CAGR (2016-2018E) 64% Visit CAGR (2016-2018E) 22% International Revenue Q3’18
Slide 4: Macro trends & strong competitive positioning create unmatched growth opportunities
Macro trends & strong competitive positioning create unmatched growth opportunities Rising costs Vendor fatigue Innovation for global workforces Employers & Insurers Convenience Financial burden Behavioral health Consumers Value-based care Physician shortages Providers Broad-based, macro trends supp
Slide 5: Only global footprint in the industry
Only global footprint in the industry Clinical, operational, client, member presence San Mateo Phoenix Dallas Toronto Boston New York Sao Paulo Santiago London Brighton Madrid Lisbon Budapest Barcelona Dubai Kuala Lumpur Shanghai Melbourne Auckland
Slide 6: 2018 Selling season highlights
2018 Selling season highlights Strong selling season across global distribution footprint Record bookings Doubled population with multiple products ~100% increase in mid-market client additions(1) +30% RFP activity Defined as 1K to 25K US Paid Members. Record number of new clients
Slide 7: 2018 Client wins
2018 Client wins Momentum across Teladoc Health’s diversified markets Employer Health Plan International Long-term Partnership Global Offering Global Offering Global Offering Hospital & Health System
Slide 8: 2018 Client wins: Significant expansion
2018 Client wins Significant expansion Selected to be virtual care platform provider Initial pilot for Tricare launched Selected to be the virtual care provider for a large population; in late stages of contracting Addition of Expert Medical Services to distribution partnership (ASO) Medicaid pilot
Slide 9: 2019: Virtual care becomes the first point of entry
Expert advice Skin issues Caregiving support Find a doctor Anxiety & depression Surgery support Anytime, anywhere care Diagnosis & treatment 2019: Virtual care becomes the first point of entry care resolution
Slide 10: Teladoc Health uniquely delivers a single, comprehensive virtual care solution
Teladoc Health uniquely delivers a single, comprehensive virtual care solution Integrated clinical services ANALYTICS BEHAVIORAL HEALTH CARE BEHAVIORAL HEALTH NAVIGATOR FIND A DOCTOR LAB TESTING CAREGIVING TOBACCO CESSATION DERMATOLOGY PEDIATRICS GENERAL MEDICAL LICENSABLE PLATFORM GLOBAL CARE ON DE
Slide 11: Breadth of portfolio drives revenue & usage
Avg. Visits per Member by Product Access(2) US Population by Product Access Count(1) Breadth of portfolio drives revenue & usage Products include General Medical, Expert Medical Services, Behavioral Health, and Dermatology. Visits per member by product access for registered members with at least one
Slide 12: Increasing constant-client utilization trends
Increasing constant-client utilization trends (1) First year utilization measured as annualized utilization of first calendar year with eligibility. Current year utilization reflects annualized YTD 2018 through November. Median Direct Employer Utilization by Cohort(1) 1.0x 1.0x 1.0x 1.0x 1.2x 1.6x 1
Slide 13: Product & marketing strength drives financial performance
Product & marketing strength drives financial performance Utilization (%)(3)(4) Consolidated Average PEPM(1)(2) US Access Fee Only. Q4 2018E reflects midpoint of guidance range. Estimate for Q4 2018E. 2018 Full-year Management Guidance; midpoint of range. Pro forma to exclude Aetna Fully Insured, Am
Slide 14: Re-affirming Q4 & FY 2018 guidance
Re-affirming Q4 & FY 2018 guidance Q4 2018E FY 2018E Revenue (M) $119–$121 $414–$416 Adjusted EBITDA (M) $4–$6 $12–$14 Visits (K) 720–820 2,500–2,600 Members (M) 22.5–23.5 EPS (GAAP) $(0.36)–$(0.38) $(1.48)–$(1.50) FY 2018 Results & FY 2019 Guidance: late February 2019
Slide 15: Teladoc Health: Compelling financial model
Teladoc Health: Compelling financial model Multiple vectors driving sustainable top-line growth in a large addressable market High degree of visibility into future revenue streams Scalable model Strong & flexible balance sheet – $473 million of cash and marketable securities on balance sheet as of S
Slide 16: Teladoc Health: Compelling financial model
Teladoc Health: Compelling financial model * Multiple vectors driving sustainable top-line growth in a large addressable market + High degree of visibility into future revenue streams + Scalable model + Strong & flexible balance sheet - $473 million of cash and marketable securities on balance sheet
Teladoc Health — Investor Presentation (January 2019) on 6ix